Immunotherapeutic approaches for hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is a cancer with a high mortality rate due to the fact that the diagnosis usually occurs at anadvanced stage. Even in case of curative surgical treatment, recurrence is common. Sorafenib and regorafenib are the only therapeutic agents that have been demonstrated to be...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Oncotarget
Main Authors: Longo, Vito, Gnoni, Antonio, Gardini, Andrea Casadei, Pisconti, Salvatore, Licchetta, Antonella, Scartozzi, Mario, Memeo, Riccardo, Palmieri, Vincenzo Ostilio, Aprile, Giuseppe, Santini, Daniele, Nardulli, Patrizia, Silvestris, Nicola, Brunetti, Oronzo
Formato: Artigo
Idioma:Inglês
Publicado: Impact Journals LLC 2017
Assuntos:
Review
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5464921/
https://ncbi.nlm.nih.gov/pubmed/28420805
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.15406
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares